Provider review
MultiMedRx review
Microdosing promotion needs a specific quote.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated October 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
Semaglutide $139 first month, then $199; tirzepatide $179, then $299
Visit MultiMedRxStandard four-week injection offers are priced; the separate microdosing promotion publishes neither its dose nor its price.
Price as published
MultiMedRx
Semaglutide $139 first month, then $199; tirzepatide $179, then $299
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by MultiMedRx (advertises in-house compounding)
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
MultiMedRx publishes enough information to separate a first-month promotion from its regular charge, which is useful. Its microdosing section is much less concrete: broad wellness language appears without the smaller dose or a price for that specific plan. A reader interested in microdosing should ask for those details before treating the standard injection offer as a low-dose product. The in-house pharmacy claim is the company’s own description and does not, by itself, establish the quality of any individual prescription.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the regular price shown beside the introductory offer
- You want messaging and nutrition guidance with treatment
Look elsewhere if
- You need a published microdose and price together
- You want the introductory offer to continue indefinitely
What it actually costs
Price as published
Semaglutide $139 first month, then $199; tirzepatide $179, then $299
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Standard four-week injection offers are priced; the separate microdosing promotion publishes neither its dose nor its price.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not stated
- Pricing
- Check plan terms
What it does well
- Regular prices are shown beside the first-month offers
- The treatment cards specify a four-week medication supply
- Follow-up messaging and nutrition guidance are described
Pharmacy, labs and oversight
MultiMedRx names its pharmacy: MultiMedRx (advertises in-house compounding). Laboratory requirements are not publicly stated; confirm them with the clinician. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What MultiMedRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNames its pharmacy: MultiMedRx (advertises in-house compounding).
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
MultiMedRx pairs clinician evaluation with compounded semaglutide or tirzepatide injections and home delivery. The treatment cards say the introductory purchase includes the evaluation, prescription when approved, four weeks of medication and shipping. The regular prices are shown beside the first-month discounts, and a six-month purchase is also promoted. The company says it compounds in-house and offers message-based support, nutrition guidance and check-ins. A separate section promotes microdosing for broad wellness goals but does not give that offering a distinct price or milligram dose. The general checkout disclosure refers to prepaid totals, so the selected plan and supply should be confirmed before payment. The public treatment information does not establish a mandatory laboratory schedule; confirm testing requirements with the clinician.
The honest cons
The introductory price does not continue on the next regular purchase
- The microdosing promotion carries no separate dose or price
- Prepayment terms need confirmation for the chosen offer
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MultiMedRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way MultiMedRx does. Both are partners: we may earn a commission if you start care through these links.
Partner
Sprout Health
$149 sema · $199 tirz
Standard plan, self-directed low dose
FDA warning letter · Sprout Health · September 2025 · addressed to Sprout Health Partners LLC dba Sprout Health. Details in our review.
Partner
Bodybuilding Health+
$179/mo sema · $209/mo tirz
Standard plan, self-directed low dose
Where this sits
#502 of 548
Ordered with the companies that pay us first, and MultiMedRx is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.